Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Redefining high risk multiple myeloma with an APOBEC/Inflammation-based classifier.
Grasedieck S, Panahi A, Jarvis MC, Borzooee F, Harris RS, Larijani M, Avet-Loiseau H, Samur M, Munshi N, Song K, Rouhi A, Kuchenbauer F. Grasedieck S, et al. Among authors: samur m. Leukemia. 2024 May;38(5):1172-1177. doi: 10.1038/s41375-024-02210-0. Epub 2024 Mar 9. Leukemia. 2024. PMID: 38461190 Free PMC article.
In Multiple Myeloma, High-Risk Secondary Genetic Events Observed at Relapse Are Present From Diagnosis in Tiny, Undetectable Subclonal Populations.
Lannes R, Samur M, Perrot A, Mazzotti C, Divoux M, Cazaubiel T, Leleu X, Schavgoulidze A, Chretien ML, Manier S, Adiko D, Orsini-Piocelle F, Lifermann F, Brechignac S, Gastaud L, Bouscary D, Macro M, Cleynen A, Mohty M, Munshi N, Corre J, Avet-Loiseau H. Lannes R, et al. Among authors: samur m. J Clin Oncol. 2023 Mar 20;41(9):1695-1702. doi: 10.1200/JCO.21.01987. Epub 2022 Nov 7. J Clin Oncol. 2023. PMID: 36343306 Free PMC article.
MUC1-C activates EZH2 expression and function in human cancer cells.
Rajabi H, Hiraki M, Tagde A, Alam M, Bouillez A, Christensen CL, Samur M, Wong KK, Kufe D. Rajabi H, et al. Among authors: samur m. Sci Rep. 2017 Aug 7;7(1):7481. doi: 10.1038/s41598-017-07850-0. Sci Rep. 2017. PMID: 28785086 Free PMC article.
Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast Cancer.
Hata T, Rajabi H, Yamamoto M, Jin C, Ahmad R, Zhang Y, Kui L, Li W, Yasumizu Y, Hong D, Miyo M, Hiraki M, Maeda T, Suzuki Y, Takahashi H, Samur M, Kufe D. Hata T, et al. Among authors: samur m. Mol Cancer Ther. 2019 Oct;18(10):1744-1754. doi: 10.1158/1535-7163.MCT-19-0156. Epub 2019 Jul 15. Mol Cancer Ther. 2019. PMID: 31308076 Free PMC article.
MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cells.
Rajabi H, Hata T, Li W, Long MD, Hu Q, Liu S, Raina D, Kui L, Yasumizu Y, Hong D, Samur M, Kufe D. Rajabi H, et al. Among authors: samur m. Oncogene. 2019 Nov;38(47):7266-7277. doi: 10.1038/s41388-019-0940-1. Epub 2019 Aug 21. Oncogene. 2019. PMID: 31435022 Free PMC article.
MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells.
Hata T, Rajabi H, Takahashi H, Yasumizu Y, Li W, Jin C, Long MD, Hu Q, Liu S, Fushimi A, Yamashita N, Kui L, Hong D, Yamamoto M, Miyo M, Hiraki M, Maeda T, Suzuki Y, Samur MK, Kufe D. Hata T, et al. Among authors: samur mk. Cancer Res. 2019 Nov 15;79(22):5711-5722. doi: 10.1158/0008-5472.CAN-19-1034. Epub 2019 Sep 13. Cancer Res. 2019. PMID: 31519689 Free PMC article.
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD, Hagiwara M, Li W, Hu Q, Liu S, Yamashita N, Fushimi A, Kui L, Samur M, Yamamoto M, Zhang Y, Zhang N, Hong D, Maeda T, Kosaka T, Wong KK, Oya M, Kufe D. Yasumizu Y, et al. Among authors: samur m. Nat Commun. 2020 Jan 17;11(1):338. doi: 10.1038/s41467-019-14219-6. Nat Commun. 2020. PMID: 31953400 Free PMC article.
134 results